✦ LIBER ✦

Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes

✍ Scribed by Gault, Victor A.; Hunter, Kerry; Irwin, Nigel; Greer, Brett; Green, Brian D.; Harriott, Patrick; O'Harte, Finbarr P.M.; Flatt, Peter R.

Book ID: 126670185
Publisher: Walter de Gruyter GmbH & Co. KG
Year: 2007
Tongue: English
Weight: 314 KB
Volume: 388
Category: Article
ISSN: 1431-6730
DOI: 10.1515/BC.2007.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Daily administration of the GIP-R antago

Daily administration of the GIP-R antagonist (Pro3)GIP in streptozotocin-induced diabetes suggests that insulin-dependent mechanisms are critical to anti–obesity-diabetes actions of (Pro3)GIP

✍ P. L. McClean; V. A. Gault; N. Irwin; J. T. McCluskey; P. R. Flatt 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Coadministration of B-type natriuretic p

Coadministration of B-type natriuretic peptide and the vasopressin-2 receptor antagonist tolvaptan: a novel physiologic strategy to enhance water and sodium excretion without adversely affecting renal or neurohumoral function in experimental congestive heart failure

✍ Lisa C Costello-Boerrigter; Guido Boerrigter; Gail J Harty; John C Burnett 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 404 KB

Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime.